Prescription of antibiotics and anxiolytics/hypnotics to asthmatic patients in general practice: a cross-sectional study based on French and Italian prescribing data
暂无分享,去创建一个
Laurent Letrilliart | David Darmon | C. van Weel | L. Letrilliart | Chris van Weel | E. van Ganse | L. Laforest | D. Darmon | F. Petrazzuoli | Eric Van Ganse | Laurent Laforest | Ferdinando Petrazzuoli | Ferdinando Petrazzuoli
[1] P. Correll,et al. Impact of asthma on self-reported health status and quality of life: a population based study of Australians aged 18–64 , 2005, Thorax.
[2] F. Haaijer-Ruskamp,et al. Asthma management in five European countries: doctors' knowledge, attitudes and prescribing behaviour. Drug Education Project (DEP) group. , 2000, The European respiratory journal.
[3] F. Fagnani,et al. Changes in osteoarthritis management by general practitioners in the COX2-inhibitor era-concomitant gastroprotective therapy. , 2004, Joint, bone, spine : revue du rhumatisme.
[4] R. Kessler,et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project , 2004, Acta psychiatrica Scandinavica. Supplementum.
[5] S. Weich,et al. Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study , 2014, BMJ : British Medical Journal.
[6] L. Fabbri,et al. Macrolides for chronic asthma. , 2005, The Cochrane database of systematic reviews.
[7] L. Salinger,et al. Asthma in pregnancy. , 1990, NAACOG's clinical issues in perinatal and women's health nursing.
[8] C. Lemière,et al. Validity of asthma diagnoses recorded in the Medical Services database of Quebec , 2006, Pharmacoepidemiology and drug safety.
[9] C. Shuldham,et al. Psychological interventions for adults with asthma: a systematic review. , 2007, Respiratory medicine.
[10] R. Araya,et al. Common mental disorders in Santiago, Chile , 2001, British Journal of Psychiatry.
[11] G. Mazzaglia,et al. Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. , 2003, Journal of public health medicine.
[12] J. Lepine,et al. Prévalence et comorbidité des troubles psychiatriques dans la population générale française : résultats de l’étude épidémiologique ESEMeD/MHEDEA 2000/ (ESEMeD) , 2005 .
[13] M. Pisani,et al. Validating smoking data from the Veteran's Affairs Health Factors dataset, an electronic data source. , 2011, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[14] C. Butler,et al. Antibiotics for sinusitis-like symptoms in primary care , 2008, The Lancet.
[15] P. Nafstad,et al. A prospective study of asthma and subsequent use of hypnotics in young adults , 2011, Pharmacoepidemiology and drug safety.
[16] Kevin B Weiss,et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. , 2004, The Journal of allergy and clinical immunology.
[17] M. Ohayon,et al. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. , 2002, The Journal of clinical psychiatry.
[18] I. Ovhed,et al. What is the future of primary care research? , 2005, Scandinavian journal of primary health care.
[19] Alastair D Hay,et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.
[20] Kayleigh Kew,et al. Macrolides for chronic asthma. , 2015, The Cochrane database of systematic reviews.
[21] F. Dubois,et al. Arrêté du 28 juillet 2009 relatif à la composition du Conseil national de l'ordre des médecins , 2009 .
[22] J. Astbury,et al. Gender disparities in mental health , 2001 .
[23] C. Lundborg,et al. Variations in asthma treatment in five European countries--judgement analysis of case simulations. , 2002, Family Practice.
[24] G. Trifirò,et al. Prevalence and antihyperglycemic prescribing trends for patients with type 2 diabetes in Italy: a 4-year retrospective study from national primary care data. , 2008, Pharmacological research.
[25] L. George,et al. Benzodiazepine anti-anxiety agents: prevalence and correlates of use in a southern community. , 1991, American journal of public health.
[26] R. Pauwels,et al. GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .
[27] H. Ashton. Psychotropic-Drug Prescribing for Women , 1991, British Journal of Psychiatry.
[28] B. Ditto,et al. What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both? , 2006, Chest.
[29] P. J. Barnes,et al. Global strategy for asthma management and prevention: GINA executive summary , 2008, European Respiratory Journal.
[30] L. Osman,et al. Factors influencing dispensing of psychotropic medications to patients with asthma: a community pharmacy-based survey. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[31] Pierre Ernst,et al. Increased risk of childhood asthma from antibiotic use in early life. , 2007, Chest.
[32] H. Goossens,et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study , 2005, The Lancet.
[33] C. van Weel,et al. Family practices registration networks contributed to primary care research. , 2006, Journal of clinical epidemiology.
[34] Herman Goossens,et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. , 2011, The Journal of antimicrobial chemotherapy.
[35] T. Pirilä,et al. Sinus aspirates and radiographic abnormalities in severe attacks of asthma. , 1994, International archives of allergy and immunology.
[36] R. Churchill,et al. Psychological therapies for generalised anxiety disorder. , 2007, The Cochrane database of systematic reviews.
[37] C J Homer,et al. Relationship between asthma medication and antibiotic use. , 2001, Chest.
[38] J. Bousquet,et al. How appropriate is asthma therapy in general practice? , 2005, Fundamental & clinical pharmacology.
[39] S. Suissa,et al. Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers , 1996, BMJ.
[40] H. Goossens,et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe, 1998-2005. , 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[41] C. O'brien. Benzodiazepine use, abuse, and dependence. , 2005, The Journal of clinical psychiatry.
[42] P. Morris,et al. WITHDRAWN: Antibiotics for persistent nasal discharge (rhinosinusitis) in children. , 2008, The Cochrane database of systematic reviews.
[43] J. Lépine,et al. [Prevalence and comorbidity of psychiatric disorders in the French general population]. , 2005, L'Encephale.
[44] G. Nocea,et al. Asthma-related resource use and cost by GINA classification of severity in three European countries. , 2006, Respiratory medicine.
[45] J P Ornato,et al. Clinical prediction rule for pulmonary infiltrates. , 1990, Annals of internal medicine.
[46] P. Demoly,et al. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years , 2012, European Respiratory Review.
[47] W. Geerts,et al. The Management of Asthma: A Case-Scenario-Based Survey of Family Physicians and Pulmonary Specialists , 2000, The Journal of asthma : official journal of the Association for the Care of Asthma.
[48] Philip Marcus,et al. Development of the asthma control test: a survey for assessing asthma control. , 2004, The Journal of allergy and clinical immunology.